title: Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
abstract: The expression of five antigens, associated with transitional cell carcinoma (TCC) of the urinary bladder on biopsies of tumors or normal urothelium, was studied by immunostaining with the corresponding monoclonal antibodies. Both tissue sections and single cell preparations were investigated with either indirect immunoperoxidase staining or immunofluorescence. All 5 antigens were expressed on the majority (70-90%) of sectioned tumor specimens from 44 TCC patients, and 4 of them were similarly expressed on single cell tumor preparations from 26 additional patients. However, in both types of preparation, the degree of expression of these antigens varied from scattered staining of less than 25% of the tumor cells to homogenous staining of all or almost all cells. This degree of expression varied individually for each of the antigens and was not related to the malignancy grade of the tumors. However, as most of the tumors were of grades II or III, no conclusions regarding the relationship of antigen expression to the aggressiveness of the tumors can be drawn. In any event, all tumors expressed at least one and mostly several of these antigens. Antigen expression on biopsies of normal bladder mucosa from TCC patients or on urothelial biopsies from patients with prostate hyperplasia was also observed on single cell specimens (34 patients) but not on sectioned material (9 patients). However, the frequency of positive specimens was much lower (4-20%). Moreover, the number of cells expressing one or, occasionally, several of the antigens in normal urothelium was small (usually less than 5%). Because of these marked differences in antigen expression between tumors and normal tissue, the results indicate that a combination of 3-5 of the antibodies used in this study may be suitable for diagnostic purposes.
authors.affiliation: Department of Immunology, University of Stockholm, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Ben-Aïssa
authors.forename: S
authors.initials: S
authors.lastname: Paulie
authors.forename: B
authors.initials: B
authors.lastname: Gustafsson
authors.forename: L
authors.initials: L
authors.lastname: Håkansson
authors.forename: M
authors.initials: M
authors.lastname: Lagerkvist
authors.forename: H
authors.initials: H
authors.lastname: Gustafson
authors.forename: C
authors.initials: C
authors.lastname: Ahlstrand
authors.forename: P
authors.initials: P
authors.lastname: Perlmann
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology*; D000912:Antibodies, Neoplasm / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000276:immunology* / Q000473:pathology; D004848:Epithelium / Q000276:immunology; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000473:pathology; D014551:Urinary Tract / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm